GNMSF - Genmab A/S (GMAB) CEO Jan van de Winkel on Q4 2021 Results - Earning Calls Transcript

Genmab A/S (GMAB) Q4 2021 Earnings Conference Call February 16, 2022, 12:00 PM ET Company Participants Jan van de Winkel – President and Chief Executive Officer Anthony Pagano – Chief Financial Officer Anthony Mancini – Chief Operation Officer Tahi Ahmadi – Chief Medical Officer Conference Call Participants Wimal Kapadia – Bernstein James Gordon – JP Morgan Kennen MacKay – RBC Paul – Guggenheim Securities Elizabeth Walton – Credit Suisse Peter Virgil – Citi Asthika Goonewardene – Truist Securities Peter Welford – Jefferies Laura – UBS Ian – Berenberg Charlie Yang – Morgan Stanley Sachin Wadhwa – Bank of America Emily Field – Barclays Presentation Jan van de Winkel Hello, and welcome to the Genmab conference call to discuss the company's financial results for the period ended December 31st, 2021. With me today to present these results is our CFO, Anthony Pagano. 6. For the Q&A we will be joined by

For further details see:

Genmab A/S (GMAB) CEO Jan van de Winkel on Q4 2021 Results - Earning Calls Transcript